Cargando…

6-Year trajectory of fasting plasma glucose (FPG) and mortality risk among individuals with normal FPG at baseline: a prospective cohort study

BACKGROUND: Higher fasting plasma glucose (FPG) levels were associated with an increased risk of all-cause mortality; however, the associations between long-term FPG trajectory groups and mortality were unclear, especially among individuals with a normal FPG level at the beginning. The aims of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wanlu, Wen, Chi Pang, Li, Wenyuan, Ying, Zhijun, Pan, Sai, Li, Yizhan, Zhu, Zecheng, Yang, Min, Tu, Huakang, Guo, Yi, Song, Zhenya, Chu, David Ta-Wei, Wu, Xifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424387/
https://www.ncbi.nlm.nih.gov/pubmed/37574540
http://dx.doi.org/10.1186/s13098-023-01146-2
_version_ 1785089665433337856
author Li, Wanlu
Wen, Chi Pang
Li, Wenyuan
Ying, Zhijun
Pan, Sai
Li, Yizhan
Zhu, Zecheng
Yang, Min
Tu, Huakang
Guo, Yi
Song, Zhenya
Chu, David Ta-Wei
Wu, Xifeng
author_facet Li, Wanlu
Wen, Chi Pang
Li, Wenyuan
Ying, Zhijun
Pan, Sai
Li, Yizhan
Zhu, Zecheng
Yang, Min
Tu, Huakang
Guo, Yi
Song, Zhenya
Chu, David Ta-Wei
Wu, Xifeng
author_sort Li, Wanlu
collection PubMed
description BACKGROUND: Higher fasting plasma glucose (FPG) levels were associated with an increased risk of all-cause mortality; however, the associations between long-term FPG trajectory groups and mortality were unclear, especially among individuals with a normal FPG level at the beginning. The aims of this study were to examine the associations of FPG trajectories with the risk of mortality and identify modifiable lifestyle factors related to these trajectories. METHODS: We enrolled 50,919 individuals aged ≥ 20 years old, who were free of diabetes at baseline, in the prospective MJ cohort. All participants completed at least four FPG measurements within 6 years after enrollment and were followed until December 2011. FPG trajectories were identified by group-based trajectory modeling. We used Cox proportional hazards models to examine the associations of FPG trajectories with mortality, adjusting for age, sex, marital status, education level, occupation, smoking, drinking, physical activity, body mass index, baseline FPG, hypertension, dyslipidemia, cardiovascular disease or stroke, and cancer. Associations between baseline lifestyle factors and FPG trajectories were evaluated using multinomial logistic regression. RESULTS: We identified three FPG trajectories as stable (n = 32,481), low-increasing (n = 17,164), and high-increasing (n = 1274). Compared to the stable group, both the low-increasing and high-increasing groups had higher risks of all-cause mortality (hazard ratio (HR) = 1.18 (95% CI 0.99–1.40) and 1.52 (95% CI 1.09–2.13), respectively), especially among those with hypertension. Compared to participants with 0 to 1 healthy lifestyle factor, those with 6 healthy lifestyle factors were more likely to be in the stable group (OR(low-increasing) = 0.61, 95% CI 0.51–0.73; OR(high-increasing) = 0.20, 95% CI 0.13–0.32). CONCLUSIONS: Individuals with longitudinally increasing FPG had a higher risk of mortality even if they had a normal FPG at baseline. Adopting healthy lifestyles may prevent individuals from transitioning into increasing trajectories. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13098-023-01146-2.
format Online
Article
Text
id pubmed-10424387
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104243872023-08-15 6-Year trajectory of fasting plasma glucose (FPG) and mortality risk among individuals with normal FPG at baseline: a prospective cohort study Li, Wanlu Wen, Chi Pang Li, Wenyuan Ying, Zhijun Pan, Sai Li, Yizhan Zhu, Zecheng Yang, Min Tu, Huakang Guo, Yi Song, Zhenya Chu, David Ta-Wei Wu, Xifeng Diabetol Metab Syndr Research BACKGROUND: Higher fasting plasma glucose (FPG) levels were associated with an increased risk of all-cause mortality; however, the associations between long-term FPG trajectory groups and mortality were unclear, especially among individuals with a normal FPG level at the beginning. The aims of this study were to examine the associations of FPG trajectories with the risk of mortality and identify modifiable lifestyle factors related to these trajectories. METHODS: We enrolled 50,919 individuals aged ≥ 20 years old, who were free of diabetes at baseline, in the prospective MJ cohort. All participants completed at least four FPG measurements within 6 years after enrollment and were followed until December 2011. FPG trajectories were identified by group-based trajectory modeling. We used Cox proportional hazards models to examine the associations of FPG trajectories with mortality, adjusting for age, sex, marital status, education level, occupation, smoking, drinking, physical activity, body mass index, baseline FPG, hypertension, dyslipidemia, cardiovascular disease or stroke, and cancer. Associations between baseline lifestyle factors and FPG trajectories were evaluated using multinomial logistic regression. RESULTS: We identified three FPG trajectories as stable (n = 32,481), low-increasing (n = 17,164), and high-increasing (n = 1274). Compared to the stable group, both the low-increasing and high-increasing groups had higher risks of all-cause mortality (hazard ratio (HR) = 1.18 (95% CI 0.99–1.40) and 1.52 (95% CI 1.09–2.13), respectively), especially among those with hypertension. Compared to participants with 0 to 1 healthy lifestyle factor, those with 6 healthy lifestyle factors were more likely to be in the stable group (OR(low-increasing) = 0.61, 95% CI 0.51–0.73; OR(high-increasing) = 0.20, 95% CI 0.13–0.32). CONCLUSIONS: Individuals with longitudinally increasing FPG had a higher risk of mortality even if they had a normal FPG at baseline. Adopting healthy lifestyles may prevent individuals from transitioning into increasing trajectories. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13098-023-01146-2. BioMed Central 2023-08-13 /pmc/articles/PMC10424387/ /pubmed/37574540 http://dx.doi.org/10.1186/s13098-023-01146-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Li, Wanlu
Wen, Chi Pang
Li, Wenyuan
Ying, Zhijun
Pan, Sai
Li, Yizhan
Zhu, Zecheng
Yang, Min
Tu, Huakang
Guo, Yi
Song, Zhenya
Chu, David Ta-Wei
Wu, Xifeng
6-Year trajectory of fasting plasma glucose (FPG) and mortality risk among individuals with normal FPG at baseline: a prospective cohort study
title 6-Year trajectory of fasting plasma glucose (FPG) and mortality risk among individuals with normal FPG at baseline: a prospective cohort study
title_full 6-Year trajectory of fasting plasma glucose (FPG) and mortality risk among individuals with normal FPG at baseline: a prospective cohort study
title_fullStr 6-Year trajectory of fasting plasma glucose (FPG) and mortality risk among individuals with normal FPG at baseline: a prospective cohort study
title_full_unstemmed 6-Year trajectory of fasting plasma glucose (FPG) and mortality risk among individuals with normal FPG at baseline: a prospective cohort study
title_short 6-Year trajectory of fasting plasma glucose (FPG) and mortality risk among individuals with normal FPG at baseline: a prospective cohort study
title_sort 6-year trajectory of fasting plasma glucose (fpg) and mortality risk among individuals with normal fpg at baseline: a prospective cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424387/
https://www.ncbi.nlm.nih.gov/pubmed/37574540
http://dx.doi.org/10.1186/s13098-023-01146-2
work_keys_str_mv AT liwanlu 6yeartrajectoryoffastingplasmaglucosefpgandmortalityriskamongindividualswithnormalfpgatbaselineaprospectivecohortstudy
AT wenchipang 6yeartrajectoryoffastingplasmaglucosefpgandmortalityriskamongindividualswithnormalfpgatbaselineaprospectivecohortstudy
AT liwenyuan 6yeartrajectoryoffastingplasmaglucosefpgandmortalityriskamongindividualswithnormalfpgatbaselineaprospectivecohortstudy
AT yingzhijun 6yeartrajectoryoffastingplasmaglucosefpgandmortalityriskamongindividualswithnormalfpgatbaselineaprospectivecohortstudy
AT pansai 6yeartrajectoryoffastingplasmaglucosefpgandmortalityriskamongindividualswithnormalfpgatbaselineaprospectivecohortstudy
AT liyizhan 6yeartrajectoryoffastingplasmaglucosefpgandmortalityriskamongindividualswithnormalfpgatbaselineaprospectivecohortstudy
AT zhuzecheng 6yeartrajectoryoffastingplasmaglucosefpgandmortalityriskamongindividualswithnormalfpgatbaselineaprospectivecohortstudy
AT yangmin 6yeartrajectoryoffastingplasmaglucosefpgandmortalityriskamongindividualswithnormalfpgatbaselineaprospectivecohortstudy
AT tuhuakang 6yeartrajectoryoffastingplasmaglucosefpgandmortalityriskamongindividualswithnormalfpgatbaselineaprospectivecohortstudy
AT guoyi 6yeartrajectoryoffastingplasmaglucosefpgandmortalityriskamongindividualswithnormalfpgatbaselineaprospectivecohortstudy
AT songzhenya 6yeartrajectoryoffastingplasmaglucosefpgandmortalityriskamongindividualswithnormalfpgatbaselineaprospectivecohortstudy
AT chudavidtawei 6yeartrajectoryoffastingplasmaglucosefpgandmortalityriskamongindividualswithnormalfpgatbaselineaprospectivecohortstudy
AT wuxifeng 6yeartrajectoryoffastingplasmaglucosefpgandmortalityriskamongindividualswithnormalfpgatbaselineaprospectivecohortstudy